MX341572B - Gel multiusos para sequedad vaginal con efecto directo y retardado. - Google Patents

Gel multiusos para sequedad vaginal con efecto directo y retardado.

Info

Publication number
MX341572B
MX341572B MX2013006406A MX2013006406A MX341572B MX 341572 B MX341572 B MX 341572B MX 2013006406 A MX2013006406 A MX 2013006406A MX 2013006406 A MX2013006406 A MX 2013006406A MX 341572 B MX341572 B MX 341572B
Authority
MX
Mexico
Prior art keywords
direct
vaginal dryness
delayed effect
gel
multipurpose
Prior art date
Application number
MX2013006406A
Other languages
English (en)
Other versions
MX2013006406A (es
Inventor
Alberto Bartorelli
Maria Rosa Gobbi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of MX2013006406A publication Critical patent/MX2013006406A/es
Publication of MX341572B publication Critical patent/MX341572B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a composiciones tópicas vaginales en forma de gel que contienen mediadores inmunológicos, factores de crecimiento, factores quimiotácticos y factores antibacterianos/antivirales extraídos de calostro bovino y opcionalmente otros ingredientes con actividad complementaria.
MX2013006406A 2010-12-09 2011-12-02 Gel multiusos para sequedad vaginal con efecto directo y retardado. MX341572B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002260A IT1405998B1 (it) 2010-12-09 2010-12-09 Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
PCT/EP2011/071612 WO2012076409A1 (en) 2010-12-09 2011-12-02 Multipurpose gel for vaginal dryness with direct and delayed effect

Publications (2)

Publication Number Publication Date
MX2013006406A MX2013006406A (es) 2014-01-31
MX341572B true MX341572B (es) 2016-08-25

Family

ID=43736916

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006406A MX341572B (es) 2010-12-09 2011-12-02 Gel multiusos para sequedad vaginal con efecto directo y retardado.

Country Status (26)

Country Link
US (1) US9248151B2 (es)
EP (1) EP2648739B1 (es)
JP (1) JP6120774B2 (es)
CN (1) CN103338778B (es)
AU (1) AU2011340757B2 (es)
BR (1) BR112013014081B1 (es)
CA (1) CA2820403C (es)
CO (1) CO6781483A2 (es)
CY (1) CY1118832T1 (es)
DK (1) DK2648739T3 (es)
EA (1) EA026198B1 (es)
ES (1) ES2624766T3 (es)
HR (1) HRP20170663T1 (es)
HU (1) HUE033257T2 (es)
IL (1) IL226764A (es)
IT (1) IT1405998B1 (es)
LT (1) LT2648739T (es)
ME (1) ME02665B (es)
MX (1) MX341572B (es)
MY (1) MY160610A (es)
PL (1) PL2648739T3 (es)
PT (1) PT2648739T (es)
RS (1) RS55910B1 (es)
SI (1) SI2648739T1 (es)
WO (1) WO2012076409A1 (es)
ZA (1) ZA201304147B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2642650C2 (ru) 2011-12-30 2018-01-25 Инномед С.А. Комбинация факторов роста, цитокинов, антибактериальных/антивирусных факторов, факторов стволовых клеток, белков комплемента с3а/с4а, иммуноглобулинов и хемотаксических факторов
EP2815757A1 (en) * 2013-06-17 2014-12-24 Hestia Investments Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa
CN105030872A (zh) * 2015-07-30 2015-11-11 太阳树（厦门）生物工程有限公司 一种玛咖提取物的提取工艺
ITUB20155902A1 (it) 2015-11-25 2017-05-25 Nathura S P A Composizione farmaceutica cicatrizzante per uso topico
NL2017656B1 (nl) * 2016-10-21 2018-04-30 Johan Wagenaar Louis Samenstelling voor slijmvliesherstel
CN107693842B (zh) * 2017-12-05 2020-05-05 湖北美尔丽生物科技有限公司 一种医用耐水凝胶及其制备方法
IT201800002990A1 (it) * 2018-02-23 2019-08-23 Biomedical Res Srl Composizione a base di una miscela di fattori biologici isolata dal colostro e oli vegetali ozonizzati per l’uso nel trattamento di vaginiti e vaginosi
CN112135621A (zh) * 2018-05-04 2020-12-25 宝洁公司 用于治疗阴道萎缩的组合物和方法
CN112088010A (zh) * 2018-05-04 2020-12-15 宝洁公司 用于治疗阴道干燥的组合物和方法
EP3603626A1 (en) * 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa
RS58997B1 (sr) 2018-09-14 2019-08-30 Fazlagic Amira Dr Kompozicija protiv starenja kože intimne regije
CN111744005B (zh) * 2020-06-24 2024-04-26 黑龙江天龙药业有限公司 一种女性下生殖道粘膜保护、再生喷剂及其制备方法
CN112999335A (zh) * 2021-02-26 2021-06-22 王利琼 一种用于女性阴道预防与治疗各种妇科炎症、抗hpv的缓释水凝胶的制备方法
MX2023012528A (es) * 2021-04-23 2023-10-31 Thomas Meneghini Desinfectante y uso del mismo.
CN114588252A (zh) * 2022-04-08 2022-06-07 暨南大学附属第一医院（广州华侨医院） 一种用于缓解阴道萎缩和干燥症的组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177223B1 (en) * 1984-09-24 1990-02-28 Michael Mezei Pharmaceutical multi-phase composition
US20030215506A1 (en) * 2002-05-17 2003-11-20 Kuhrts Eric H Methods and compositions for enhancement of creatine transport
AU2004228759B2 (en) 2003-04-09 2010-04-08 Dolhay Klinika Egeszsegugyi Kft. Sexual hygienic composition
CN1557340A (zh) * 2004-01-15 2004-12-29 高春平 生长因子和免疫球蛋白制剂
WO2006035418A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Microcapsules comprising a methylxanthine and a corticosteroid
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
EP1879908B1 (en) * 2005-05-10 2014-01-08 Murray Goulburn Co-Operative Co Limited Immunoglobulin fraction and process therefor
KR100509681B1 (ko) * 2005-05-27 2005-08-23 주식회사 렉스진바이오텍 포유동물의 초유 또는 유즙 유래의 유청분리분획을포함하는 성장 촉진용 식품 조성물
ITMI20051777A1 (it) * 2005-09-23 2007-03-24 Pharmaproducts Uk Ltd Composizioni a base di colostro per il trattamento della secchezza vaginale
US8226975B2 (en) * 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
TR201900010T4 (tr) * 2006-07-03 2019-02-21 Jean Paul Perraudin Hipohalit ve/veya hipotiyosiyanit içeren antimikrobiyal bileşimler ve bunların kullanımları.
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
NZ587901A (en) 2008-03-13 2012-11-30 Immuron Ltd Immuno-modulating compositions for the treatment of immune-mediated disorders
EP2280999B1 (en) * 2008-05-15 2017-09-06 Biosys Health Inc. Process for producing milk fractions rich in secretory immunoglobulins
IT1392471B1 (it) 2008-11-25 2012-03-09 Pharmafilm S R L Collutorio in forma di sospensione stabile comprendente microsfere che incorporano un principio attivo.

Also Published As

Publication number Publication date
CA2820403A1 (en) 2012-06-14
CO6781483A2 (es) 2013-10-31
IL226764A (en) 2016-12-29
US9248151B2 (en) 2016-02-02
PL2648739T3 (pl) 2017-08-31
WO2012076409A1 (en) 2012-06-14
MY160610A (en) 2017-03-15
SI2648739T1 (sl) 2017-05-31
AU2011340757B2 (en) 2016-10-27
ES2624766T3 (es) 2017-07-17
CY1118832T1 (el) 2018-01-10
ME02665B (me) 2017-06-20
MX2013006406A (es) 2014-01-31
AU2011340757A1 (en) 2013-07-04
ITMI20102260A1 (it) 2012-06-10
CN103338778A (zh) 2013-10-02
LT2648739T (lt) 2017-04-25
CN103338778B (zh) 2018-02-02
IT1405998B1 (it) 2014-02-06
BR112013014081B1 (pt) 2020-03-17
CA2820403C (en) 2018-05-01
ZA201304147B (en) 2014-08-27
RS55910B1 (sr) 2017-09-29
EP2648739B1 (en) 2017-02-15
BR112013014081A2 (pt) 2016-09-20
HRP20170663T1 (hr) 2017-06-30
US20140322329A1 (en) 2014-10-30
EA026198B1 (ru) 2017-03-31
EA201390663A1 (ru) 2013-11-29
JP6120774B2 (ja) 2017-04-26
HUE033257T2 (hu) 2017-11-28
DK2648739T3 (en) 2017-05-01
PT2648739T (pt) 2017-05-23
EP2648739A1 (en) 2013-10-16
JP2013544858A (ja) 2013-12-19

Similar Documents

Publication Publication Date Title
MX341572B (es) Gel multiusos para sequedad vaginal con efecto directo y retardado.
IL289249A (en) Modified Aav and preparations, methods and uses for gene transfer to cells, organs and tissues
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
WO2011152566A3 (en) Composition for inducing proliferation or accumulation of regulatory t cells
IN2012DN00486A (es)
WO2013006490A3 (en) Antibodies that specifically bind to tim3
IN2015DN03322A (es)
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
WO2011159770A3 (en) Methods and compositions for promoting hair growth
GB201316021D0 (en) Vitamin D composition
MX2015005384A (es) Miembros de union para il-1 beta.
WO2015092549A3 (en) Biologicals for plants
IN2014DN10639A (es)
MX2021016114A (es) Formulaciones para estabilizar la humedad en alimentos musculares.
CA2834182C (en) Honey composition with l-alanyl-l-glutamine
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
IN2012DN01214A (es)
WO2011019867A3 (en) Dietary supplements and methods for treating pain and inflammation
WO2014031982A3 (en) Methods and compositions for treating pain
TR201005327A2 (tr) Sinerjik farmasötik formülasyonlar.
WO2013100585A3 (ko) 세복수초 추출물 또는 그 유효물질을 이용한 항암제 조성물
WO2012108745A3 (ko) 조각인 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
WO2011073439A3 (en) Use of peptides as antidandruff agents
UA65758U (en) Composition of cake "mitsnyi horishok" (tough nut)
刘容容 Allogeneic hematopoietic stem cell transplantation in 24 patients with β-thalassemia major

Legal Events

Date Code Title Description
FG Grant or registration